Monopar Therapeutics Inc. (MNPR)
NASDAQ: MNPR · Real-Time Price · USD
87.68
+0.05 (0.06%)
Jun 26, 2026, 4:00 PM EDT - Market closed
Monopar Therapeutics Stock Forecast
Stock Price Forecast
The 9 analysts with 12-month price forecasts for Monopar Therapeutics stock have an average target of 111.89, with a low estimate of 101 and a high estimate of 130. The average target predicts an increase of 27.61% from the current stock price of 87.68.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Monopar Therapeutics stock from 13 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 10 | 10 | 10 | 10 | 9 | 9 |
| Buy | 4 | 4 | 4 | 4 | 4 | 4 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 14 | 14 | 14 | 14 | 13 | 13 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barclays | Barclays | Buy Maintains $125 | Buy | Maintains | $125 | +42.56% | Jun 29, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $105 | Buy | Reiterates | $105 | +19.75% | Jun 29, 2026 |
| Piper Sandler | Piper Sandler | Buy Maintains $101 | Buy | Maintains | $101 | +15.19% | Jun 2, 2026 |
| BTIG | BTIG | Buy Maintains $104 | Buy | Maintains | $104 | +18.61% | Jun 2, 2026 |
| Lake Street | Lake Street | Buy Maintains $103 | Buy | Maintains | $103 | +17.47% | Jun 1, 2026 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
15.40M
EPS This Year
-2.90
from -1.85
EPS Next Year
-3.16
from -2.90
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | n/a | 34.9M | |
| Avg | n/a | 15.4M | |
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2027 | 2028 |
|---|---|---|
| High | - | 693.4% |
| Avg | - | 437.9% |
| Low | - | 290.8% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -1.36 | -1.12 | |
| Avg | -2.90 | -3.16 | |
| Low | -5.45 | -4.78 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.